Streetbeat News

Equity Actions

AIRE

ReAlpha Tech shares are trading lower following the company's filing of a prospectus for the offering of up to 1.67 million common units at $12 each.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:42 pm

SGD

Safe & Green Development Corp (NASDAQ:SGD) stock surged 84% to $5.59 after announcing it will not proceed with a previously contemplated common stock offering. The company requested the SEC to withdraw its Registration Statement and confirmed that no shares have been or will be sold under this statement. The decision was due to changed circumstances since the initial filing. The stock experienced multiple trading halts during Thursday's and Friday's sessions.

Portfolio Pulse from Henry Khederian

November 17, 2023 | 4:27 pm

BBLG

Bone Biologics Corp (NASDAQ:BBLG) stock plummeted by 38% after announcing a public offering and private placement at $0.64 per share, with additional unregistered warrants. The company aims to raise approximately $729,200 for clinical trials, patent expansion, and operational needs. The offering is expected to close around November 20, with warrants exercisable for five and a half years at $0.52 per share. H.C. Wainwright & Co. is managing the offering.

Portfolio Pulse from Henry Khederian

November 17, 2023 | 4:20 pm

TGT

Big-money investors have shown a bearish stance on Target (NYSE:TGT), with options trades indicating a sentiment split of 27% bullish and 72% bearish. Benzinga's options scanner revealed 11 unusual options trades, with a price range target from $90 to $130 over the last 3 months. The largest trades included a bullish call with a strike price of $105 expiring on 11/24/23 and a bearish call with a strike price of $100 expiring on 01/19/24. Target is the sixth-largest U.S. retailer, operating over 1,900 stores with over $100 billion in sales. The stock price is currently up 0.34% at $130.38, with potential overbought signals from RSI indicators. Analysts have mixed ratings on TGT, with an average target price of $149 and varying recommendations from Buy to Market Perform.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:15 pm

CGC

Canopy Growth Corporation (CGC) has been approved by the Ontario Superior Court of Justice to sell assets of BioSteel Sports Nutrition Inc. under the Companies' Creditors Arrangement Act. The sale includes assets of BioSteel Canada and BioSteel Manufacturing, LLC, which is expected to improve Canopy Growth's balance sheet. CFO Judy Hong stated that ceasing to fund BioSteel has already enhanced the company's financial position, and the sale proceeds will further improve it. Canopy's shares were up 3.2216% at $0.5479 per share.

Portfolio Pulse from Jelena Martinovic

November 17, 2023 | 4:05 pm

DLTR

Dollar Tree (NASDAQ:DLTR) is evaluated against competitors in the Food & Staples Retailing industry. It has a lower P/E, P/B, and higher P/S ratios compared to the industry average, suggesting undervaluation but also potential overvaluation in sales. Dollar Tree's ROE, EBITDA, and gross profit are below the industry average, indicating possible inefficiencies, while its revenue growth outperforms the industry. The company's lower debt-to-equity ratio suggests a stronger financial position relative to its top 4 peers.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:00 pm

CTSH

The article compares Cognizant Tech Solns (CTSH) to its IT Services industry peers, analyzing financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Cognizant, with a lower P/E, P/B, and P/S than the industry average, may be undervalued. However, its ROE, EBITDA, gross profit, and revenue growth are below the industry average, indicating potential profitability and growth challenges. The company's lower debt-to-equity ratio suggests a stronger financial position compared to its top 4 peers.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:00 pm

DELL

Dell Technologies Inc. (NYSE:DELL) stock has seen a 0.36% increase in the current session, trading at $72.80. Over the past month and year, the stock has risen by 11.67% and 78.21%, respectively. The company's P/E ratio of 27.9 is below the industry average of 29.29, which could suggest undervaluation or potentially weaker growth prospects compared to industry peers.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:00 pm

CYTO

Altamira Therapeutics Ltd (NASDAQ:CYTO) is trading over 200% higher after announcing the sale of a 51% stake in its subsidiary Altamira Medica AG to a Swiss private equity investor. The deal includes a cash consideration of CHF 2.04 million and future licensing income. The company will retain a 49% stake in Medica and expects a financial gain of approximately $5.2 million from the transaction. Altamira's CEO anticipates major growth from 2024 and a strategic repositioning into a focused RNA delivery company.

Portfolio Pulse from Vandana Singh

November 17, 2023 | 3:58 pm

AIRE

ReAlpha, a real estate technology company, has filed a prospectus with the SEC for the offering of up to 1.67 million common units at a price of $12 per unit, as detailed in their Form S-11 filing.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:41 pm